Bracco Wins FDA Clearance for AI Brain Aneurysm Tool
Bracco and Avicenna.AI have received U.S. Food and Drug Administration (FDA) 510(k) clearance for UPTUNITY | Aneurysm, an AI-enabled software solution designed to assist radiologists in detecting and monitoring brain aneurysms on computed tomography angiography (CTA) images. Announced on November 13, 2026, the clearance marks the first offering in Bracco’s new UPTUNITY portfolio and expands…
